Nordic Pharmacovigilance Day

Nordic Pharmacovigilance Day 2026

Pharmacovigilance in the Nordics: Innovation, Collaboration, Safety

The 13th Nordic Pharmacovigilance Day, taking place on 11 November 2026 in Copenhagen, will once again bring together stakeholders from across the Nordic region and beyond to reflect on the continuing evolution of pharmacovigilance and its critical role in safeguarding public health. As healthcare systems, regulatory frameworks, and technologies continue to develop, pharmacovigilance is undergoing profound transformation, requiring new ways of thinking, working, and collaborating.

Pharmacovigilance today extends far beyond traditional safety reporting. It is increasingly shaped by  diverse data sources, digitalisation, and rising expectations for transparency and proactive risk management. These changes challenge organisations to adapt their processes, governance, and competencies, while maintaining a strong focus on scientific rigor, regulatory compliance, and patient safety.

Nordic Pharmacovigilance Day 2026 provides a forum to explore how the discipline is responding to these shifts, to share experiences and best practices, and to discuss future directions in a rapidly changing environment. By fostering dialogue between regulators, industry, and academia, the meeting aims to support continuous improvement in pharmacovigilance systems and to strengthen collaboration across the region in the interest of safer use of medicines.

Key Conference Topics

The agenda of this pharmacovigilance conference is designed to explore the most pressing and evolving areas in drug safety, from clinical trial data collection to the integration of innovative technologies and regulatory updates. Key topics include:

• Challenges of collecting safety data from clinical trial
• Changes in PV legislation, according to EMA pharmacovigilance guidelines
• Artificial Intelligence in Pharmacovigilance and the Report of the CIOMS Working Group XIV
• GVP Inspection experiences
• PV from a local affiliate perspective
• Role of RWE in safety monitoring
• The impact of digital media and social media in pharmacovigilance

The presentations and workshop offer a variety of perspectives, reflecting insights from the pharmaceutical industry, regulatory agencies, service providers, and other stakeholders, fostering a comprehensive understanding of current challenges and emerging trends in pharmacovigilance.

Scientific Board

•  Wasim Anwar - Pharmacovigilance Expert
• Caroline Susanne Sandström - Pharmacovigilance and Quality Expert
• Mette Stie Kallesøe - Head of Pharmacovigilance, QPPV at Hansa Biopharma AB

Who should attend Nordic Pharmacovigilance Day 2026?

The Nordic pharmacovigilance conference is tailored for pharmacovigilance professionals, including:

• PV professionals, QPPVs, drug safety and patient safety managers
• QA personnel
• GVP Inspectors and auditors
• Regulatory affairs specialists with a focus on drug safety
• CROs & vendors handling patient safety data
• Healthcare professionals and pharmacists in pharmaceutical industry & regulatory agencies

Nordic Pharmacovigilance Day – Building Opportunities

The Nordic Pharmacovigilance Day is a leading conference for professionals working in pharmacovigilance and related fields across the Nordic region. The event provides a dedicated platform to transform pharmacovigilance and drug safety knowledge into practical solutions for everyday practice, while also offering opportunities for networking and exchanging ideas with peers and experts.

Organized by LS Academy, a trusted provider of life sciences training and conferences since 2010, Nordic PHV Day brings together the Nordic pharmacovigilance community to share expertise, foster collaboration, and advance patient safety.